Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

NCT01090453 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus
Hepatitis B
Haemophilus Influenzae Type b
Poliomyelitis
Acellular Pertussis
Diphtheria
Neisseria Meningitidis

Interventions

BIOLOGICAL: GSK2202083A vaccine
BIOLOGICAL: Prevenar 13®
BIOLOGICAL: Infanrix hexa™
BIOLOGICAL: Menjugate®
BIOLOGICAL: Rotarix™

Sponsor

GlaxoSmithKline